glp 1 for crohn's Pharmacological interventions obesity in patients with inflammatory bowel disease: A systematic review of GLP-1 receptor agonist efficacy and safety Weight Loss Medications & IBD

Nearly seven million Americans now take GLP-1 drugs like Ozempic and Wegovy, with Morgan Stanley projecting that number could reach 24 million by 2035, The New York Times reported in January

Although some variability existed between studies, the overall direction of benefit was consistent, highlighting their potential role in improving long-term outcomes among HFpEF patients

Conversely, Hantson and coworkers [83] recently reported the case of a 47-year-old epileptic man in whom parenteral VPA therapy was associated with a severe hyperammonaemic encephalopathy (peak ammonia concentration 411 mol/l) without any biological signs of hepatotoxicity

J.SharmaA.LeeH